Polyclonal Rabbit anti‑Human SST / Somatostatin Antibody (Cy3, aa1‑116, WB) LS‑C698759
Polyclonal Rabbit anti‑Human SST / Somatostatin Antibody (Cy3, aa1‑116, WB) LS‑C698759
Antibody:
SST / Somatostatin Rabbit anti-Human Polyclonal (aa1-116) (Cy3) Antibody
Overview
Antibody:
SST / Somatostatin Rabbit anti-Human Polyclonal (aa1-116) (Cy3) Antibody
Specifications
Description
Somatostatin antibody LS-C698759 is a Cy3-conjugated rabbit polyclonal antibody to Somatostatin (SST) (aa1-116) from human. It is reactive with human and rat. Validated for WB.
Target
Human SST / Somatostatin
Synonyms
SST | Somatostatin-28 | SMST | Somatostatin-14 | Somatostatin
Reactivity
Human, Rat
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant SST (Met1-Cys116) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against SST.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse, Rat, Pig
Applications:
IHC, Immunofluorescence
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen
Species:
Human, Rat
Applications:
Western blot
Species:
Human, Mouse, Rat, Pig
Applications:
ELISA
Species:
Human
Applications:
IHC
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024